Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)
Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)(6699-46-3)
- Name: Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)
- Synonyms:Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methylacryloyl)-, ion(1-), (?à)- (8CI); Quinoxaline,1,2,3,4-tetrahydro-1,4-dimethacryloyl- (7CI); NSC 90846
- Molecular Formula:C16H18 N2 O2
- Molecular Weight:270.3263
- CAS Registry Number:6699-46-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.6699-46-3 Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.6699-46-3 6699-46-3
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.6699-46-3 Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.6699-46-3 Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 97468-12-7/Phosphoric acid,C8-10-branched and linear alkyl esters, potassium salts
- 94200-33-6/sodium (1,4-dioxo-2-sulphonatobutane-1,4-diyl)bis(iminoethylene) distearate
- 40330-50-5/Cobalt(2+), [2-(amino-κN)ethanethiolato-κS]bis(1,2-ethanediamine-κN1,κN2)-, (OC-6-33)-, perchlorate (1:2)
- 2581-43-3/HYDROQUINONE DITOSYLATE
- 83704-28-3/1,3,4,9-TETRACHLORODIBENZOFURAN
- 73768-75-9/2-[(3-nitropyridin-2-yl)sulfanyl]-1H-benzimidazole
- 68512-42-5/Propanol,2,2'-iminobis-, N-coco alkyl derivs.
- 18073-32-0/6H-Pyrido[4,3-b]carbazole,9-methoxy-5,6,11-trimethyl-
- 96470-93-8/Fatty acids, C14-18 and C16-18-unsatd, compds. with 2-(8-heptadecenyl)-4,5-dihydro-4-methyl-4-oxazolemethanol
- 56926-00-2/2-butyl-7-ethyloctahydro-6H-pyrazino[1,2-c]pyrimidin-6-one
- 162666-36-6/1H-Naphtho[1,8a-c]furan-4-carboxaldehyde,3,3a,6,6a,7,8,9,10-octahydro-3-hydroxy-7,7-dimethyl-1,10-dioxo-,(3S,3aS,6aS,10aR)-
- 20949-81-9/2-PHENYL-1,3-THIAZOLE-4-CARBALDEHYDE
- 7232-77-1/2,6-bis(3-methylphenyl)-4-(2,4,6-triphenylpyridin-1-yl)phenolate
- 57963-08-3/2-AMINO-5,6-DIMETHYLPYRIDINE
- 1204-29-1/1-ethyl-2,4-dinitrobenzene
- 78581-99-4/1H-Benzimidazole,5,6-difluoro-(9CI)
- 6332-23-6/3-bromo-1-[2-(4-bromophenyl)-2-oxoethyl]quinolinium
- 685888-87-3/4-{[(Z)-(2,4-dioxo-2H-chromen-3(4H)-ylidene)methyl]amino}benzoate
- 83732-84-7/2-NAPHTHYLAMINE-4,6,8-TRISULFONIC ACID
- 6699-46-3/Quinoxaline,1,2,3,4-tetrahydro-1,4-bis(2-methyl-1-oxo-2-propenyl)- (9CI)
- 94230-68-9/tripotassium hydrogen [(dodecylimino)bis(methylene)]bisphosphonate
- 6166-98-9/(5E)-5-(3-chloro-4-ethoxybenzylidene)-1-(3-ethoxyphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
- 5326-81-8/2-chloro-N-hexylacetamide
- 94158-54-0/[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl] hydrogen fumarate
- 23443-59-6/pentan-3-yl
- 31398-96-6/tris(phenylethynyl)phosphane oxide
- 110071-61-9/Myristoyltransferase,protein N-
- 12220-38-1/C.I. Acid Red 316(8CI,9CI)
- 65912-84-7/(2S,5R,6R)-6-{[({[2-(4-acetylpiperazin-1-yl)-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-6-yl]carbonyl}amino)(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- 93573-08-1/1,3-Isobenzofurandione, hexahydro-5-methyl-, reaction products with 4,4-(1-methylethylidene)bis(2,6-dibromophenol)